Search Ontology:
ChEBI
bitolterol mesylate
- Term ID
- CHEBI:3134
- Synonyms
-
- 4-(2-(tert-butylamino)-1-hydroxyethyl)-o-phenylene di-p-toluate mesylate
- 4-(2-(tert-butylamino)-1-hydroxyethyl)-o-phenylene di-p-toluate methanesulfonate
- 4-[2-(tert-butylamino)-1-hydroxyethyl]-o-phenylene di-p-toluate mesylate
- 4-[2-(tert-butylamino)-1-hydroxyethyl]-o-phenylene di-p-toluate methanesulfonate
- 4-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,2-diyl bis(4-methylbenzoate) mesylate
- 4-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,2-diyl bis(4-methylbenzoate) methanesulfonate
- bitolterol mesilat
- bitolterol mesilate
- bitolterol methanesulfonate salt
- N-(2-{3,4-bis[(4-methylbenzoyl)oxy]phenyl}-2-hydroxyethyl)-2-methylpropan-2-aminium mesylate
- N-(2-{3,4-bis[(4-methylbenzoyl)oxy]phenyl}-2-hydroxyethyl)-2-methylpropan-2-aminium methanesulfonate
- Definition
- The methanesulfonate salt of bitolterol. A beta2-adrenergic receptor agonist, it is used for relief of bronchospasm in conditions such as asthma, chronic bronchitis and emphysema.
- References
-
- Beilstein:4103660
- CAS:30392-41-7
- DrugBank:DB00901
- KEGG:D00684
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has subtype
-
- has_part
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from bitolterol mesylate
Phenotype where environments contain bitolterol mesylate
Phenotype modified by environments containing bitolterol mesylate
Human Disease Model